Arcellx (ACLX) Cash from Financing Activities (2021 - 2025)

Arcellx's quarterly Cash from Financing Activities came in at $1.6 million in Q4 2025, up 127.16% year-on-year from $719328.2 in Q4 2024, and down 98.1% quarter-over-quarter from $86.1 million in Q3 2025.

Arcellx has reported Cash from Financing Activities for 5 years, with the latest figure at $1.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 127.16% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $98.5 million (up 509.08% YoY), and the FY2025 full-year result was $98.5 million, up 509.08% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at $1.6 million, down from $86.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $188.6 million in Q4 2023, with the low at -$10.4 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is $36.2 million, with a median of $928500.0 recorded in 2022.
  • Year-over-year, Cash from Financing Activities jumped 14252.44% in 2023 and slumped 9088.79% in 2024.
  • Tracing ACLX's Cash from Financing Activities over 5 years: stood at $15000.0 in 2021, then soared by 8660.0% to $1.3 million in 2022, then jumped by 14252.44% to $188.6 million in 2023, then plunged by 103.19% to -$6.0 million in 2024, then soared by 127.16% to $1.6 million in 2025.
  • The last three Cash from Financing Activities figures came in at $1.6 million (Q4 2025), $86.1 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 1.63 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.63 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 86.10 Mn
Sep 30, 2025 86.10 Mn
Jun 30, 2025 10.26 Mn
Jun 30, 2025 10.26 Mn
Mar 31, 2025 543,000.00
Mar 31, 2025 543,000.00
Dec 31, 2024 -6.02 Mn
Dec 31, 2024 -6.02 Mn
Sep 30, 2024 -4.66 Mn
Sep 30, 2024 -4.66 Mn
Jun 30, 2024 -10.43 Mn
Jun 30, 2024 -10.43 Mn
Mar 31, 2024 -2.99 Mn
Mar 31, 2024 -2.99 Mn
Dec 31, 2023 188.59 Mn
Dec 31, 2023 188.59 Mn
Sep 30, 2023 -4.99 Mn
Sep 30, 2023 -4.99 Mn
Jun 30, 2023 116,000.00
Jun 30, 2023 116,000.00
Mar 31, 2023 95.45 Mn
Mar 31, 2023 95.45 Mn
Dec 31, 2022 1.31 Mn
Dec 31, 2022 1.31 Mn
Sep 30, 2022 -9.71 Mn
Sep 30, 2022 -9.71 Mn
Jun 30, 2022 121.46 Mn
Jun 30, 2022 121.46 Mn
Mar 31, 2022 139.56 Mn
Mar 31, 2022 139.56 Mn
Dec 31, 2021 15,000.00
Dec 31, 2021 15,000.00
Sep 30, 2021 -467,000.00
Sep 30, 2021 -467,000.00
Jun 30, 2021 37.28 Mn
Jun 30, 2021 37.28 Mn
Mar 31, 2021 81.63 Mn
Mar 31, 2021 81.63 Mn